Google and GSK create a world leader in ‘bioelectronics’
The two companies will invest £540 million in the new UK-based business over 7 years, as well as contributing intellectual property rights to Galvani. Galvani will “enable the research, development, and commercialisation of bioelectronic medicines.” […]